hi cafa and others, I have noticed eric van cutsem seems to have quite a good relationship with the company (providing positive feedback on SIRFLOX and actually coming to sydney last year to talk to institutional investors/analysts), I think this bodes well for SIRT's chances in being included in european treatment practice guidelines (which are followed more closely in europe than say, for example, US oncologists following the NCCN guidelines)
eric van cutsem actually authored the last ESMO treatment guidelines (2014) for mCRC, accessible here:
http://www.esmo.org/Guidelines/Gastrointestinal-Cancers/Metastatic-Colorectal-Cancer
note this was the first time SIRT was included, and this was before the sirlfox data was available
I think he will provide some exciting commentary at the upcoming conference, should be interesting!
- Forums
- ASX - By Stock
- SRX
- ESMO 17 th World Congress on Gastrointestinal Cancer
ESMO 17 th World Congress on Gastrointestinal Cancer, page-2
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SRX (ASX) to my watchlist
|
|||||
Last
17.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $74.27M |
Open | High | Low | Value | Volume |
17.5¢ | 18.0¢ | 17.5¢ | $132.6K | 758.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 449688 | 17.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
18.0¢ | 955405 | 27 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 449688 | 0.175 |
5 | 1608822 | 0.170 |
1 | 18186 | 0.165 |
1 | 2577 | 0.097 |
1 | 4000 | 0.075 |
Price($) | Vol. | No. |
---|---|---|
0.180 | 945405 | 26 |
0.185 | 38427 | 3 |
0.190 | 220025 | 8 |
0.195 | 20478 | 2 |
0.200 | 181416 | 6 |
Last trade - 15.47pm 30/08/2024 (20 minute delay) ? |
Featured News
SRX (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online